echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The price of household commonly used drugs has increased, and the price of some drugs has doubled

    The price of household commonly used drugs has increased, and the price of some drugs has doubled

    • Last Update: 2021-02-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to China Voice News, erythromycin eye cream, compound licorice tablets are a must-have medicine for many families, mosquito bites, colds and coughs and other minor disasters can be used, a few cents of the price also left many people with good memories. However, these household drugs have recently begun to rise in price, in some places, the price of cheap drugs even doubled, some drugs in just one year the price of 20 times, even if it is still difficult to find a drug. Where's the cheap medicine that the common people are familiar with? Who helped drive up the price of the drug?
    Jinan resident Ms. Yang's eyes recently caught fire again, ben thought of the community service center to buy a few more erythromycin eye cream spare, but was told that there is no stock, and not sure when to come back. After running three or four pharmacies, Ms. Yang finally bought erythromycin eye cream, so that she could not imagine, in a short period of half a year, the original few cents a piece of ointment has risen to four pieces of six, "although not too expensive, can afford, but such a short period of time from a few hairs to this price, psychologically unacceptable."
    reporters then in Jinan several pharmacies on a field visit found that not only the price of erythromycin eye cream has increased, such as glucosin, lipto, compound licorice tablets and other drugs prices have increased several times. In the past 6 cents a bottle of glucosin tablets now rose to 8.5 yuan / bottle; the treatment of coronary heart disease Liputo used to be 7 yuan per box, now the price of a box rose to more than 60 yuan; and for the treatment of acute non-lymphoblastic leukemia, the price of high tributylase injection, the price has risen from 5 yuan a year ago to 110 yuan now, the price has increased more than 20 times.
    , Jinan's shortage of cheap medicines and sharp price increases are not an exception in the country. In recent years in many parts of the country, cheap drugs frequently reported the news has been repeatedly exposed. At the end of 2015, a 13-year-old patient in Anhui urgently needed the cheap "life-saving medicine" Pingyangmycin, in Anhui Province found only 4 boxes of inventory;
    Ma Zhiqiang, head of a pharmaceutical company in Shandong Province, said that the rise in the price of cheap drugs does not rule out that some pharmaceutical companies through a monopoly position to raise drug prices, "for example, some time ago fried hot fish protein, there may be only two production, the north is Beijing's manufacturers, the south is Shanghai's enterprise production, they joined forces to monopolize the market, put pressure on the government and society to raise prices, this phenomenon is also there." In
    price monopoly, the rise in the price of cheap drugs is more of a market action. Many companies have had to stop production when the cost of raw materials, labor, logistics and so on for the production of cheap drugs is rising, even approaching the price. Stoppages are bound to exacerbate shortages of cheap drugs, which will fuel soaring prices. Mr. Liu, head of research and development of a pharmaceutical factory in Shandong Province, said that cheap drugs are considered to be "effective, no money way", any pharmaceutical production enterprises can not afford to lose money production, they can hardly rely on conscience and responsibility to run, "do not increase the price of drugs on the death, now it is true that many cheap drugs have disappeared, some pharmaceutical companies are also forced, the original price can not be maintained, such as low-cost drugs after bidding may not be able to win, even after the Chinese medicine is not necessarily sold out." Some
    play the trick of "new bottles of old wine" when it comes to producing cheap medicines. The same medicine, change the name, change the packaging, change the approval, the value can be doubled or even dozens of times. As a result, some cheap drugs take off their "cheap" coats and re-launch them in brand new packaging, and every change of clothes means a surge in prices. Take anti-inflammatory drugs, for example, from cyclocycline to amoxicillin to cephalosporine metamorphosis, followed by prices from a few cents to four or five dollars to more than twenty dollars.
    The cheap medicine represented by erythromycin ointment and compound licorice tablets, also known as essential drugs, refers to medicines that can meet basic medical and health needs, are suitable in dosage form, are guaranteed to supply, are available at the grass-roots level, and are fairly accessed by the people. However, at the 2016 National Conference, Yu Mingde, president of the China Pharmaceutical Enterprise Management Association and the China Pharmaceutical Entrepreneurs Association, pointed out that cheap drugs are disappearing at a rate of dozens of species a year. Even if the efficacy is good, but the price of drugs is low, enterprises do not produce, the common people do not buy drugs, cheap drugs are entering a dead cycle. How to solve the problem of shortage of cheap medicines?Liu Guoen, a member of the State Council's National Advisory Committee of Experts on Medical Reform, believes that the supply of cheap drugs needs the government's "tangible hand" to support the bottom,
    "through market means is not solved, there is only one way, is through the hands of the government's public finances to organize a considerable number of government-owned drug factory, let it lose money to operate, the government's public finances, then can solve this problem." Industry
    say the shortage of cheap medicines is hard to change in the short term. In the future in the pharmaceutical industry, only the government, pharmaceutical companies and hospitals continue to play a game, and finally find a market balance point, it is possible to make cheap drugs really circulate to patients. (CCTV)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.